188 related articles for article (PubMed ID: 23285196)
1. Multipotent cancer stem cells derived from human malignant peritoneal mesothelioma promote tumorigenesis.
Varghese S; Whipple R; Martin SS; Alexander HR
PLoS One; 2012; 7(12):e52825. PubMed ID: 23285196
[TBL] [Abstract][Full Text] [Related]
2. Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays.
Chapel DB; Stewart R; Furtado LV; Husain AN; Krausz T; Deftereos G
Hum Pathol; 2019 May; 87():11-17. PubMed ID: 30794891
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of malignant peritoneal mesothelioma: A population-based study.
Salo SAS; Ilonen I; Laaksonen S; Myllärniemi M; Salo JA; Rantanen T
Cancer Epidemiol; 2017 Dec; 51():81-86. PubMed ID: 29080447
[TBL] [Abstract][Full Text] [Related]
4. Molecular Characterization of Peritoneal Mesotheliomas.
Offin M; Yang SR; Egger J; Jayakumaran G; Spencer RS; Lopardo J; Nash GM; Cercek A; Travis WD; Kris MG; Ladanyi M; Sauter JL; Zauderer MG
J Thorac Oncol; 2022 Mar; 17(3):455-460. PubMed ID: 34648949
[TBL] [Abstract][Full Text] [Related]
5. The role of imaging in diagnosis and management of malignant peritoneal mesothelioma: a systematic review.
Carlson B; Harmath C; Turaga K; Kindler HL; Armato SG; Straus C
Abdom Radiol (NY); 2022 May; 47(5):1725-1740. PubMed ID: 35257201
[TBL] [Abstract][Full Text] [Related]
6. Analysis of prognostic factors of patients with malignant peritoneal mesothelioma.
Yin W; Zheng G; Yang K; Song H; Liang Y
World J Surg Oncol; 2018 Mar; 16(1):44. PubMed ID: 29506546
[TBL] [Abstract][Full Text] [Related]
7. Putative cancer stem cells may be the key target to inhibit cancer cell repopulation between the intervals of chemoradiation in murine mesothelioma.
Wu L; Blum W; Zhu CQ; Yun Z; Pecze L; Kohno M; Chan ML; Zhao Y; Felley-Bosco E; Schwaller B; de Perrot M
BMC Cancer; 2018 Apr; 18(1):471. PubMed ID: 29699510
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of a new malignant peritoneal mesothelioma cell line, KOG-1, from the ascitic fluid of a patient with pemetrexed chemotherapy resistance.
Akahane T; Hirasawa A; Imoto I; Okubo A; Itoh M; Nanki Y; Yoshihama T; Tominaga E; Aoki D
Hum Cell; 2020 Jan; 33(1):272-282. PubMed ID: 31583526
[TBL] [Abstract][Full Text] [Related]
9. Identification of cancer stem cell markers in human malignant mesothelioma cells.
Ghani FI; Yamazaki H; Iwata S; Okamoto T; Aoe K; Okabe K; Mimura Y; Fujimoto N; Kishimoto T; Yamada T; Xu CW; Morimoto C
Biochem Biophys Res Commun; 2011 Jan; 404(2):735-42. PubMed ID: 21163253
[TBL] [Abstract][Full Text] [Related]
10. Cells isolated from residual intracranial tumors after treatment express iPSC genes and possess neural lineage differentiation plasticity.
Palanichamy K; Jacob JR; Litzenberg KT; Ray-Chaudhury A; Chakravarti A
EBioMedicine; 2018 Oct; 36():281-292. PubMed ID: 30269995
[TBL] [Abstract][Full Text] [Related]
11. Malignant Peritoneal Mesothelioma Associated With Endometriosis: A Clinicopathologic Study of 15 Cases.
Malpica A; Euscher ED; Marques-Piubelli ML; Miranda RN; Fournier KF; Raghav KP; Ramalingam P
Int J Gynecol Pathol; 2022 Jan; 41(1):59-67. PubMed ID: 33577225
[TBL] [Abstract][Full Text] [Related]
12. Forecast of Malignant Peritoneal Mesothelioma Mortality in Italy up to 2040.
Oddone E; Bollon J; Nava CR; Minelli G; Imbriani M; Consonni D; Marinaccio A; Magnani C; Barone-Adesi F
Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33379304
[TBL] [Abstract][Full Text] [Related]
13. IMP3 as a prognostic biomarker in patients with malignant peritoneal mesothelioma.
Hui S; Guo-Qi Z; Xiao-Zhong G; Chun-Rong L; Yu-Fei L; Dong-Liang Y
Hum Pathol; 2018 Nov; 81():138-147. PubMed ID: 30031101
[TBL] [Abstract][Full Text] [Related]
14. Distinct populations of tumor-initiating cells derived from a tumor generated by rat mammary cancer stem cells.
Zucchi I; Astigiano S; Bertalot G; Sanzone S; Cocola C; Pelucchi P; Bertoli G; Stehling M; Barbieri O; Albertini A; Schöler HR; Neel BG; Reinbold RA; Dulbecco R
Proc Natl Acad Sci U S A; 2008 Nov; 105(44):16940-5. PubMed ID: 18957543
[TBL] [Abstract][Full Text] [Related]
15. A Histomorphologic Grading System That Predicts Overall Survival in Diffuse Malignant Peritoneal Mesothelioma With Epithelioid Subtype.
Valente K; Blackham AU; Levine E; Russell G; Votanopoulos KI; Stewart JH; Shen P; Geisinger KR; Sirintrapun SJ
Am J Surg Pathol; 2016 Sep; 40(9):1243-8. PubMed ID: 27438989
[TBL] [Abstract][Full Text] [Related]
16. First-line chemotherapy with pemetrexed plus cisplatin for malignant peritoneal mesothelioma.
Fujimoto E; Kijima T; Kuribayashi K; Negi Y; Kanemura S; Mikami K; Doi H; Kitajima K; Nakano T
Expert Rev Anticancer Ther; 2017 Sep; 17(9):865-872. PubMed ID: 28594258
[TBL] [Abstract][Full Text] [Related]
17. Tumor cells positive and negative for the common cancer stem cell markers are capable of initiating tumor growth and generating both progenies.
Huang SD; Yuan Y; Tang H; Liu XH; Fu CG; Cheng HZ; Bi JW; Yu YW; Gong DJ; Zhang W; Chen J; Xu ZY
PLoS One; 2013; 8(1):e54579. PubMed ID: 23349932
[TBL] [Abstract][Full Text] [Related]
18. Cancer stem cells in solid tumors.
Ailles LE; Weissman IL
Curr Opin Biotechnol; 2007 Oct; 18(5):460-6. PubMed ID: 18023337
[TBL] [Abstract][Full Text] [Related]
19. [Pathological classification of malignant peritoneal mesothelioma and comparative analysis with peritoneal carcinomatosis].
Zhang GZ; Zheng GQ; Wei F; Liu YY; Song H; Liang YF
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2023 Jul; 41(7):541-546. PubMed ID: 37524680
[No Abstract] [Full Text] [Related]
20. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
